RaQualia Pharma Inc.
Status: Publicly traded
Direct answer
RaQualia Pharma Inc. is publicly traded on JPX under the ticker 4579.T.
RaQualia Pharma Inc., established in 2008 and based in Nagoya, Japan, is a pharmaceutical company dedicated to the global research and development of innovative drug compounds. Its human therapeutic pipeline features several key candidates. Tegoprazan, designed to treat gastroesophageal reflux disease (GERD), is currently undergoing Phase 1 clinical trials in the United States. Grapiprant is in Phase II development...
Can you invest in RaQualia Pharma Inc.?
Yes. RaQualia Pharma Inc. trades publicly on JPX as 4579.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for RaQualia Pharma Inc.
Detailed equity research is provided by MarketSnap.